Abstract
A few reports have demonstrated that cognitive or physical dysfunction is associated with increased mortality in very elderly patients, those over 80 years of age. Using simple clinical tests, we evaluated the impact of cognitive or physical dysfunction on future total and cardiovascular deaths. We conducted a multicenter prospective study of 523 extremely elderly outpatients, aged ≥ 80 years (mean±SD age: 84±5.3 years). These patients had normal activities of daily living at baseline. They were followed for an average of 34 months (range: 3–70 months), after which the total and cardiovascular deaths were evaluated. Cognitive and physical functions were evaluated by a short-term memory test using visual working memory and the getup-and-go test, respectively. Seventy-five deaths, including 36 cardiovascular deaths, occurred during the follow-up period. In a Cox regression analysis model controlling for age, sex, body mass index (BMI), diastolic blood pressure (BP), cholesterol level, and history of cardiovascular diseases, cognitive dysfunction was found to be an independent risk factor for total death (p<0.001), and cognitive dysfunction (p<0.001) and physical dysfunction (p=0.05) were independent risk factors for cardiovascular death. The determinants of cognitive dysfunction were associated with a lower diastolic BP (p=0.04) adjusted for age, BMI, and a history of cardiovascular disease. Cognitive function, which was associated with lower BP levels, and physical function were the independent predictors of total and cardiovascular mortality among all cardiovascular risk factors in the very elderly, those at least 80 years of age.
Similar content being viewed by others
Article PDF
References
Neale R, Brayne C, Johnson AL : Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over. Int J Epidemiol 2001; 30: 1383–1388.
Smits CH, Deeg DJ, Kriegsman DM, Schmand B : Cognitive functioning and health as determinants of mortality in an older population. Am J Epidemiol 1999; 150: 978–986.
Miller GJ, Cooper JA, Beckles GL : Cardiorespiratory fitness, all-cause mortality, and risk of cardiovascular disease in Trinidadian men—the St James survey. Int J Epidemiol 2005; 34: 1387–1394.
Schupf N, Tang MX, Albert SM, et al: Decline in cognitive and functional skills increases mortality risk in nondemented elderly. Neurology 2005; 65: 1218–1226.
Larson EB, Shadlen MF, Wang L, et al: Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004; 140: 501–509.
Ganguli M, Rodriguez EG : Reporting of dementia on death certificates: a community study. J Am Geriatr Soc 1999; 47: 842–849.
Kilander L, Nyman H, Boberg M, Hansson L, Lithell H : Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998; 31: 780–786.
Corrada M, Brookmeyer R, Kawas C : Sources of variability in prevalence rates of Alzheimer's disease. Int J Epidemiol 1995; 24: 1000–1005.
Hy LX, Keller DM : Prevalence of AD among whites: a summary by levels of severity. Neurology 2000; 55: 198–204.
Podsiadlo D, Richardson S : The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39: 142–148.
Ganguli M, Dodge HH, Shen C, DeKosky ST : Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004; 63: 115–121.
Lopez OL, Jaqust WJ, DeKosky ST, et al: Prevalence and classification of mild cognitive impairment in the Cardiovascular Health study Cognition Study: Part 1. Arch Neurol 2003; 60: 1385–1389.
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E : Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–308.
Bennett DA, Wilson RS, Schneider JA, et al: Natural history of mild cognitive impairment in older persons. Neurology 2002; 59: 198–205.
Kannus P, Parkkari J, Koskinen S, et al: Fall-induced injuries and deaths among older adults. JAMA 1999; 281: 1895–1899.
Tinetti ME, Williams CS : Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med 1997; 337: 1279–1284.
Takata Y, Ansai T, Soh I, et al: Association between body mass index and mortality in an 80-year-old population. J Am Geriatr Soc 2007; 55: 913–917.
Flodin L, Svensson S, Cederholm T : Body mass index as a predictor of 1 year mortality in geriatric patients. Clin Nutr 2000; 19: 121–125.
Panza F, D'Introno A, Colasicco AM, et al: Lipid metabolism in cognitive decline and dementia. Brain Res Rev 2006; 51: 275–292.
White H, Pieper C, Schmader K : The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc 1998; 46: 1223–1227.
Gueyffier F, Bulpitt C, Boissel JP, et al: Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA group. Lancet 1999; 353: 793–796.
Tzourio C, Anderson C, Chapman N, et al: Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163: 1069–1075.
Ruitenberg A, Skoog I, Ott A, et al: Blood pressure and risk of dementia: results from the Rotterdam Study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 2001; 12: 33–39.
Boshuizen HC, Izaks GJ, van Buuren S, Ligthart GJ : Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ 1998; 316: 1780–1784.
Kaplan NM : Clinical Hypertension. Baltimore, Williams & Wilkins, 1998.
Shepherd J, Blauw GJ, Murphy MB, et al: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002; 360: 1623–1630.
Sacks FM, Pfeffer MA, Moye LA, et al: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med 1996; 335: 1001–1009.
Hakim AA, Curb JD, Burchfiel CM, et al: Screening for coronary heart disease in elderly men based on current and past cholesterol levels. J Clin Epidemiol 1999; 52: 1257–1265.
Elkind MSV, Sciacca R, Boden-Albala B, Rundek T, Paik MC, Sacco RL : Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke 2006; 37: 13–19.
Barnes DE, Yaffe K, Satariano WA, Tager IB : A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J Am Geriatr Soc 2003; 51: 459–465.
Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K : Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 2001; 58: 498–504.
Larson EB, Wang L : Exercise, aging, and Alzheimer disease. Alzheimer Dis Assoc Disord 2004; 18: 54–56.
Pate RR, Pratt M, Blair SN, et al: Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402–407.
Rogers RL, Meyer JS, Mortel KF : After reaching retirement age physical activity sustains cerebral perfusion and cognition. J Am Geriatr Soc 1990; 38: 123–128.
Gomez-Pinilla F, So V, Kesslak JP : Spatial learning and physical activity contribute to the induction of fibroblast growth factor: neural substrates for increased cognition associated with exercise. Neuroscience 1998; 85: 53–61.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hoshide, S., Ishikawa, J., Eguchi, K. et al. Cognitive Dysfunction and Physical Disability Are Associated with Mortality in Extremely Elderly Patients. Hypertens Res 31, 1331–1338 (2008). https://doi.org/10.1291/hypres.31.1331
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1331
Keywords
This article is cited by
-
Isoflurane-Induced Postoperative Neurovascular and Cognitive Dysfunction Is Associated with VEGF Overexpression in Aged Rats
Journal of Molecular Neuroscience (2019)
-
Mobility as a predictor of all-cause mortality in older men and women: 11.8 year follow-up in the Tromsø study
BMC Health Services Research (2017)
-
Renin–angiotensin–aldosterone system has a pivotal role in cognitive impairment
Hypertension Research (2013)
-
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension
Hypertension Research (2011)
-
Association of Poor Physical Function and Cognitive Dysfunction With High Nocturnal Blood Pressure Level in Treated Elderly Hypertensive Patients
American Journal of Hypertension (2011)